The Valley Desk

NCT03373877 · Interventional trial

Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis

Overall registry status Terminated

Phase 1

Conditions Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov